S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer
S-1 adjuvant chemotherapy is commonly administered postoperatively for stage II and III advanced gastric cancer.
This study included 113 patients treated with S-1 adjuvant chemotherapy after surgery for stage II and III advanced gastric cancer. These patients were divided into 4 groups: group A (n = 63), who had a longer duration (≥6 months) and earlier S-1 administration (≤6 weeks) after surgery; group B (n = 16), who had a longer and later S-1 administration (>6 weeks) after surgery; group C (n = 27), who had a shorter duration (<6 months) and earlier S-1 administration after surgery; and group D (n = 7), who had a shorter and later S-1 administration after surgery.
The recurrence rates in groups A, B, C, and D were 15.7, 43.8, 44.4, and 57.1 %, respectively (A vs. B, p < 0.05, A vs. C and D, p < 0.01). The survival time of group A was significantly longer than that of other groups (p < 0.005). In addition, the survival time of patients with severe complications was significantly shorter than that of patients with non-severe complications (p < 0.05). An earlier S-1 administration after surgery was the only independent prognostic factor in the multivariate analysis.
The prognosis of advanced gastric cancer was significantly related to the start of S-1 adjuvant treatment within 6 weeks after surgery.
KeywordsGastric Cancer Adjuvant Chemotherapy Adjuvant Treatment Advanced Gastric Cancer Pancreatic Fistula
- 2.Japanese Gastric Cancer Association. Gastric Cancer Treatment Guideline. 3rd ed. Tokyo, Japan: Kanehara, 2010.Google Scholar
- 5.O’Connel MJ, Laurie JA, Kahan M, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol. 1998;16:295–300.Google Scholar
- 13.Lerut T, Moons J, Coosemans W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systemic grading of complications using the modified Clavien classification. Ann Surg. 2009;250:798–807.PubMedCrossRefGoogle Scholar
- 19.Japanese Gastric Cancer Association. Japan Classification of Gastric Carcinoma, 14th ed. Japan: Kanehara, 2010.Google Scholar
- 22.Cox DR. Regression models and life tables. J R Stat B. 1972;35:187–220.Google Scholar